Efficient Trial Design - FDA Approval of Valbenazine for Tardive Dyskinesia.
作者信息
Davis Michael C, Miller Brian J, Kalsi Jasmeet K, Birkner Thomas, Mathis Mitchell V
机构信息
From the Division of Psychiatry Products (M.C.D., B.J.M., J.K.K., M.V.M.) and the Division of Biometrics I (T.B.), Center for Drug Evaluation and Research, Silver Spring, MD; and the University of North Carolina Kenan-Flagler School of Business, Chapel Hill (B.J.M.).
出版信息
N Engl J Med. 2017 Jun 29;376(26):2503-2506. doi: 10.1056/NEJMp1704898. Epub 2017 May 10.
PMID:28489481
Abstract
摘要
Zotero 插件